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Heart failure due to dilated cardiomyopathy is frequently caused by myocarditis. However, the pathogenesis of myocarditis 
remains incompletely understood. Here, we report the presence of neutrophil extracellular traps (NETs) in cardiac tissue of 
patients and mice with myocarditis. Inhibition of NET formation in experimental autoimmune myocarditis (EAM) of mice 
substantially reduces inflammation in the acute phase of the disease. Targeting the cytokine midkine (MK), which mediates 
NET formation in vitro, not only attenuates NET formation in vivo and the infiltration of polymorphonuclear neutrophils 
(PMNs) but also reduces fibrosis and preserves systolic function during EAM. Low-density lipoprotein receptor–related 
protein 1 (LRP1) acts as the functionally relevant receptor for MK-induced PMN recruitment as well as NET formation. In 
summary, NETosis substantially contributes to the pathogenesis of myocarditis and drives cardiac inflammation, probably 
via MK, which promotes PMN trafficking and NETosis. Thus, MK as well as NETs may represent novel therapeutic targets for 
the treatment of cardiac inflammation.
Midkine drives cardiac inflammation by promoting 
neutrophil trafficking and NETosis in myocarditis
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Introduction
Myocarditis is the underlying cause of dilated cardiomyopa-
thy (DCM) in 20–50% of DCM patients in Europe and North 
America (Cooper et al., 2014). While acute myocarditis is often 
triggered by cardiotropic viruses (e.g., enteroviruses, adenovi-
ruses, parvovirus B19 [PVB19], and others), transition to auto-
immune-mediated inflammation may sustain myocarditis upon 
eradication of the virus, eventually leading to an end-stage heart 
failure phenotype of inflammatory DCM (Caforio et al., 2013). 
The involvement of adaptive immunity in the pathogenesis of 
myocarditis and inflammatory DCM has been widely acknowl-
edged and investigated (Heymans et al., 2016). However, the role 
of the innate immune response, especially polymorphonuclear 
neutrophils (PMNs) as potential drivers of persistent cardiac 
inflammation, has only been marginally addressed. PMNs can 
maintain inflammation by a specific process called NETosis 
(Warnatsch et al., 2015). Upon activation by various stimuli, 
including viruses, bacteria, or cytokines, PMNs eject their DNA 
decorated with antimicrobial proteins (e.g., myeloperoxidase 
[MPO] or neutrophil elastase [NE]; Brinkmann et al., 2004; 
Kenny et al., 2017; Toussaint et al., 2017). Neutrophil extracellular 
traps (NETs) can enhance inflammation as well as tissue injury 
by different mechanisms, including direct damage, platelet ac-
tivation, triggering autoantibody production, and reducing the 
threshold for T cell activation (Tillack et al., 2012; Sørensen and 
Borregaard, 2016; Martinod et al., 2017; McDonald et al., 2017; 
Nakazawa et al., 2017).
PMNs are recruited to the tissue during inflammation, where 
they can undergo NETosis. The 13-kD cytokine midkine (MK) is 
critical for PMN adhesion and subsequent extravasation during 
acute inflammation (Weckbach et al., 2014) and mediates im-
mune cell recruitment in chronic inflammation in mouse mod-
els of multiple sclerosis or rheumatoid arthritis (Maruyama 
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et al., 2004; Wang et al., 2008). Restrictive expression under 
physiological conditions in adults makes MK an interesting 
therapeutic target (Muramatsu and Kadomatsu, 2014). Previous 
data suggested that MK mediates PMN adhesion by binding to 
the low-density lipoprotein receptor–related protein 1 (LRP1), 
a member of the low-density lipoprotein (LDL) receptor family 
(Weckbach et al., 2014). LRP1 is a widely expressed transmem-
brane receptor that is primarily involved in endocytosis of ex-
tracellular proteins or other cell surface receptors (Lillis et al., 
2008). In addition, LRP1 can interact with transmembrane recep-
tors, modulating intracellular signaling upon ligand binding. In 
macrophages, LRP1 interacts with adhesion molecules of the β2 
integrin family, which are critical for PMN recruitment and acti-
vation during inflammation (Ranganathan et al., 2011; Herter and 
Mayadas, 2014). However, the potential impact of the MK–LRP1 
axis on PMN recruitment during acute or chronic inflammation 
is still unknown.
In this study, we identify NETs in endomyocardial biopsies 
(EMBs) of patients suffering from myocarditis. Moreover, we 
decipher the functional importance of NETs for myocarditis and 
delineate the mechanistic link between NETs and MK. We report 
a new molecular axis between MK and LRP1 that is critical for 
β2 integrin–dependent PMN recruitment steps and the forma-
tion of NETs. In a mouse model of myocarditis, targeting NETs 
or MK inhibits the development of the disease and preserves 
heart function.
Results
Targeting MK reduces PMN infiltration and NETosis in the 
inflamed myocardium
Initially, we explored the presence of NETs in myocardial tissue 
of patients with acute myocarditis. Clinical patient characteris-
tics are shown in Table 1. In paraffin-embedded sections of EMBs 
from 14 individuals with myocarditis, we were able to detect NETs 
in EMBs of two patients with evidence of PVB19 infection and in 
all eight patients without evidence of PVB19 infection (Table 1). 
NETs were identified by the colocalization of the H2A–H2B–DNA 
complex, MPO, and citrullinated histone 3 (H3Cit). PMN infiltra-
tion was found in EMBs of all patients. A representative image 
indicating the presence of NETs in the inflamed cardiac tissue 
is shown in Fig. 1 a. To study the functional relevance of NETs in 
myocarditis, we applied a mouse model of experimental autoim-
mune myocarditis (EAM) using s.c. injection of α myosin heavy 
chain peptide with CFA and sham-treated animals for control, 
which received vehicle and CFA. We stained heart sections of 
mice at day 21 after induction of EAM, which represents the 
peak of inflammatory infiltrates in this model (Afanasyeva et al., 
2001). Here, we were able to detect DNA decorated with NE and 
H3Cit, indicating the presence of NETs in this model (Fig. 1 d). 
To elucidate the relevance of NET formation on inflammation, 
we evaluated leukocyte infiltration in EAM (referred to as EAM 
score) after treatment of mice with DNase or the protein-argi-
nine deiminase inhibitor Cl-amidine (Cl-amid). Here, DNase 
was administered twice daily and Cl-amid once daily from day 
1 until day 21 after induction of EAM, as illustrated in Fig. S1 a. 
Leukocyte infiltration in EAM mice was significantly increased 
compared with sham-treated control mice (sham, Fig. 1 b). Strik-
ingly, treatment with DNase or Cl-amid significantly reduced 
leukocyte infiltration to levels of sham-treated control mice. 
Moreover, the heart/body weight ratio of EAM mice treated with 
DNase or Cl-amid was significantly diminished compared with 
vehicle-treated EAM mice (Fig. 1 c). As expected, NET formation 
(indicated by H3Cit and NE staining in the cardiac tissue) was re-
duced compared with vehicle-treated mice after targeting NETs 
(Fig. S1 b). In cardiac sections of sham-treated control mice with-
out induction of EAM, no NETs were detectable. These findings 
suggest that NETs promote cardiac inflammation during EAM. 
Since the cytokine MK is critical for PMN adhesion and subse-
quent recruitment during inflammatory processes (Weckbach et 
al., 2014), we investigated whether MK impacts PMN infiltration 
in our model. First, we evaluated whether MK expression is al-
tered during cardiac inflammation. Indeed, MK mRNA expres-
sion was significantly increased in cardiac tissue of EAM mice at 
day 21 compared with sham-immunized mice at the same time 
point (Fig. S2 a). Next, MK was targeted with an antibody (Ab) 
specifically blocking the N-terminal domain of MK (anti-N-MK). 
Here, the anti-N-MK Ab was administered twice a week from day 
1 until day 21 after induction of EAM, as illustrated in Fig. S2 b. 
Using this approach, we found a substantially reduced number of 
infiltrated PMN in EAM mice (768 ± 55 vs. 158 ± 86 PMN/mm2; 
Fig. 1, e and f). In line with this observation, the absolute num-
ber of NET+ PMNs was significantly reduced after blocking MK 
during EAM compared with vehicle-treated EAM mice (40 ± 6 vs. 
5 ± 2 NET+ PMN; Fig. 1 g). Strikingly, the number of NET+ PMNs 
in the percentage of all extravasated PMNs was also dramatically 
decreased after inhibition of MK compared with vehicle-treated 
EAM mice (5.1 ± 0.5 vs. 0.9 ± 0.6 NET+ PMN [%]; Fig. 1 h), sug-
gesting a contribution of MK on NETosis on top of its effects on 
PMN recruitment.
The N-terminal domain of MK is critical for PMN 
infiltration in myocarditis
Next, we elucidated the impact of MK on the acute phase of 
myocarditis. Histological analysis of leukocyte infiltration in 
myocardial sections revealed a significantly diminished number 
of infiltrated leukocytes after application of the anti-N-MK Ab 
compared with vehicle-treated mice at day 21 after induction 
of EAM (Fig. 2 a). Similar to the findings after treatment with 
DNase or Cl-amid, the heart/body weight ratio was significantly 
reduced upon administration of the anti-N-MK Ab, suggesting 
that blocking MK protects the heart from the deteriorating effect 
of myocarditis (Fig. 2 b). To study whether infiltration of specific 
leukocyte subsets in EAM was affected by MK blockade, we in-
vestigated digested hearts of EAM mice upon administration of 
the anti-N-MK Ab or isotype control treatment at day 21 after 
induction of EAM using flow cytometry. By staining the pan-leu-
kocyte marker CD45, we were able to confirm that infiltration 
of leukocytes was significantly diminished after MK inhibition 
compared with the isotype control (Fig. 2 c). Administration of 
the anti-N-MK Ab significantly reduced the number of CD45+/
CD11b+/Gr-1+ cells compared with isotype controls. Similar re-
sults were obtained by analysis of Ly6G+ cells. This effect was 
not observed in the CD45+/CD11b+/Gr-1− cell population predom-
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inantly consisting of monocytes and macrophages. However, 
targeting the N-terminal domain of MK led to a reduced infil-
tration of CD4+ T helper cells, whereas proliferation of splenic 
CD4+ T cells after stimulation with anti-CD3/CD28 beads was not 
affected by blocking MK, indicating that targeting the N-terminal 
domain of MK did not attenuate T cell proliferation (Fig. S2 c). 
Moreover, expression of the classical proinflammatory cytokine 
macrophage inflammatory protein 2-α (MIP2-α) was not signifi-
cantly changed after blocking MK, suggesting that MK may not 
simply exert its effect by promoting expression of proinflamma-
tory cytokines (Fig. S2 d). Interestingly, blocking the C-terminal 
MK domain (anti-C-MK) did not reduce infiltration of CD45+, 
CD45+/CD11b+/Gr-1+, CD45+/CD11b+/Gr-1− or CD4+ cells compared 
with the appropriate isotype control in our model (Fig. 2 d), sug-
gesting that the N-terminal domain of MK, but not the C-termi-
nal domain, is critically required for leukocyte infiltration in 
this model. Interestingly, MK was expressed in the perivascular 
compartment of the inflamed cardiac tissue, suggesting that it 
may directly foster leukocyte infiltration in this model, as de-
scribed earlier for the inflamed mouse cremaster muscle model 
(Weckbach et al., 2014; Fig. 2 e). Blood vessel–associated MK ex-
pression was not detectable in the cardiac tissue obtained from 
sham-treated control mice.
Targeting MK reduces postinflammatory fibrosis 
and heart failure
To determine whether MK-mediated leukocyte infiltration af-
fects transition to postinflammatory fibrosis and dysfunction 
of the heart, we evaluated cardiac fibrosis and dysfunction after 
anti-N-MK Ab or vehicle treatment at day 63 of EAM. We eval-
uated the amount of collagen in cardiac muscle sections as an 
indicator for cardiac fibrosis after Masson’s trichrome staining 
(Fig. 3 a). As expected, detailed analysis using a semiquantitative 
fibrosis score revealed a significant increase of fibrotic tissue in 
the myocardium of EAM mice compared with sham-treated con-
trol animals (Fig. 3 b). MK blockade with an anti-N-MK Ab sig-
nificantly reduced fibrosis compared with vehicle-treated EAM 
mice. No effect was observed for IgG1 isotype Ab–treated mice 
compared with vehicle-treated animals (Fig. S3 a). These find-
ings suggest that inhibition of MK not only diminishes leukocyte 
infiltration into the cardiac tissue but also reduces cardiac fibro-
sis. Next, we studied whether blocking MK also protects systolic 
function during EAM. Transthoracic echocardiography at day 
63 (Fig. 3 c) revealed that fractional shortening (Fig. 3 d) as well 
as left ventricular ejection fraction (Fig. 3 e) were significantly 
preserved in anti-N-MK Ab–treated, but not vehicle-treated, 
EAM mice compared with sham-treated control animals (Fig. 3, 
d and e; and Video 1). There was no difference between treat-
ment with vehicle or anti-N-MK Ab–matched IgG1 isotype con-
trol (Fig. S3, b and c). These results implicate that MK plays a 
role for inflammation and cardiac dysfunction in this model. To 
study whether anti-N-MK Ab was able to inhibit leukocyte ad-
hesion, the critical prerequisite for extravasation, we conducted 
intravital microscopy of postcapillary venules in the cremaster 
muscle 2 h after intrascrotal application of TNFα, which mainly 
attracts PMNs within this time period (Weckbach et al., 2014; 
see also Fig. 4 e). Consistent with the results in MK−/− animals 
in this model (Weckbach et al., 2014), rolling flux fraction and 
Table 1. Patients with myocarditis
Patient Age Sex IHCa PVB19 PMN NETs Medication Symptoms LVEF at 
diagnosis (%)
Follow up 
(yr)
LVEF at 
follow up
1 47 f + + + − BB, ACEI, diuretics Heart failure 10 3 32%
2 29 f + + + − BB, ACEI, MRA, diuretics Heart failure 28 11 41%
3 48 m + + + − BB, ACEI, MRA, diuretics Heart failure 29 None —
4 36 m + + + − BB, ACEI, corticosteroids Cardiac arrest 30 <1 Normalized
5 44 m + + + + BB, ACEI, diuretics Heart failure 
and angina 
pectoris
37 None —
6 30 f + + + + BB, ACEI, diuretics Heart failure 45 10 Normalized
7 24 f + − + + ACEI LV thrombus Normal None —
8 55 m + − + + BB, ACEI Heart failure 30 10 Normalized
9 75 f + − + + BB, MRA, diuretics Angina pectoris 30 None —
10 46 m + − + + BB, ACEI, MRA, diuretics Heart failure 27 <1 40%
11 64 m + − + + BB, ACEI, diuretics Heart failure 25 <1 27%
12 56 m + − + + BB, ACEI, MRA, diuretics Heart failure 18 <1 45%
13 Unknown m + − + + Unknown Unknown Unknown Unknown Unknown
14 37 m + − + + BB, ACEI, MRA, diuretics Heart failure 23 None —
ACEI, angiotensin-converting enzyme inhibitor; BB, beta blocker; f, female; LV, left ventricle; LVEF, left ventricular ejection fraction; m, male; MRA, 
mineralocorticoid receptor antagonist.
a≥ 14 leukocytes/mm2 and HLA-DR overexpression.
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Figure 1. NETs contribute to the pathogenesis of myocarditis. (a) Confocal immunofluorescence images of an EMB of patient 6 suffering from PVB19-pos-
itive myocarditis (see Table 1). Top: Images show staining of H2A-H2B-DNA, MPO, and H3Cit as well as the merged image. Bar, 20 µm. Bottom: Magnification 
of a selected area of the merged confocal image (box) from the top panel. Arrows indicate NETs. Bar, 10 µm. (b and c) EAM score (b) as well as evaluation of 
the heart/body weight ratio (c) at day 21 after induction of EAM or sham immunization (sham; mean EAM score, 0.5 ± 0.19; mean heart/body weight ratio, 0.57 
± 0.01). Mice were treated with DNase (EAM + DNase: mean EAM score, 0.8 ± 0.19; mean heart/body weight ratio, 0.62 ± 0.005), Cl-amid (EAM + Cl-amid: 
mean EAM score, 0.9 ± 0.20; mean heart/body weight ratio, 0.62 ± 0.01), or vehicle as control (EAM + vehicle: mean EAM score, 1.7 ± 0.25; mean heart/body 
weight ratio, 0.71 ± 0.04) as indicated. n = 8 for sham group; n = 26 for EAM groups. (d) Left: Representative confocal images of cardiac sections of immunized 
WT mice at day 21 after induction of EAM (EAM + vehicle). Images show staining of DNA, NE, and H3Cit as well as the merged image. Bars, 20 µm. Right: 
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rolling velocity were not affected by blocking MK (Fig. 3, f and 
g). However, adhesion was significantly reduced after treatment 
with the anti-N-MK Ab compared with the appropriate isotype 
control (Fig. 3 h). Hematopoietic parameters were not affected by 
the anti-N-MK Ab (Fig. 3 i). Thus, the anti-N-MK Ab was able to 
significantly inhibit leukocyte trafficking in inflammation.
The MK receptor LRP1 is critical for PMN recruitment and 
cardiac inflammation
Previous data suggested that LRP1 may represent the func-
tional receptor for MK on PMN during the recruitment process 
(Weckbach et al., 2014). To investigate whether PMN trafficking is 
compromised in the absence of LRP1, we performed intravital mi-
croscopy in postcapillary venules of the cremaster muscle 2 h after 
intrascrotal application of TNFα in LRP1fl/fl/vav-cre− (LRP1ctrl) 
and LRP1fl/fl/vav-cre+ (LRP1cKO) mice with a specific knock-out of 
LRP1 in the hematopoietic system (Fig. S4, a and b). Rolling flux 
fraction as well as rolling velocity were not altered in the absence 
of LRP1 compared with control mice (Fig. 4, a and b). However, 
leukocyte adhesion was significantly reduced in LRP1cKO animals 
compared with LRP1ctrl mice to a similar extent as after blocking 
MK (Fig. 4 c and Video 2). Hematopoietic parameters were sim-
ilar in both mouse strains (Fig. 4 d). Extravasation of PMN into 
the inflamed cremaster muscle tissue was significantly compro-
mised in the absence of LRP1 in the hematopoietic system when 
compared with control animals in this model, as analyzed by 
histology (Fig. S4 c and Fig. 4 e). In contrast, diminished recruit-
ment of eosinophils or lymphocytes, basophils, and monocytes 
(“Others”) was not detected in LRP1cKO compared with LRP1ctrl 
mice in this model (Fig. 4 e). To investigate whether LRP1 may 
also be important during EAM, we targeted LRP1 using the inhib-
itor receptor-associated protein (RAP), which blocks all members 
of the LDL receptor family. Here we used a chemically modified 
more stable form of RAP (Prasad et al., 2015). Due to fast clear-
ance of RAP, miniosmotic pumps releasing RAP constantly were 
s.c. implanted. Continuous RAP administration over 21 d after 
induction of EAM reduced leukocyte infiltration in EAM mice 
significantly compared with vehicle-treated control mice (Fig. 
S4, d and e), suggesting that LRP1 may be functionally involved 
in cardiac inflammation. To study whether LRP1 may regulate the 
function of the β2 integrin lymphocyte function–associated anti-
gen 1 (LFA-1; CD11a/CD18), which is critical for induction of PMN 
adhesion in the cremaster model (Ding et al., 1999), we analyzed 
the colocalization of LRP1 and CD11a using spinning-disk confo-
cal microscopy of murine WT PMN (mPMN) in microflow cham-
bers in vitro. We found increased colocalization and clustering 
of LRP1 with CD11a on the cell surface exclusively upon adhesion 
(Fig. 4, f and g; and Video 3). Quantitative analysis revealed a sig-
nificantly elevated intensity per colocalization area of LRP1 and 
CD11a after adhesion compared with rolling, confirming the ris-
ing colocalization of both molecules upon the onset of adhesion 
(Fig. 4 h). To rule out unspecific clustering and colocalization, we 
analyzed the cell surface expression of LRP1 and Gr-1 as control 
during the process of rolling and adhesion (Fig. 4 f ). We found 
clustering of LRP1 during adhesion but no specific colocalization 
between LRP1 and Gr-1 in the clustered cell surface area (Fig. 4 g 
and Video 4). Accordingly, the intensity of the area of colocal-
ization of LRP1 and Gr-1 did not increase during transition from 
rolling to adhesion (Fig. 4 h). These findings indicate that LRP1 
and CD11a specifically cluster and colocalize upon induction of 
adhesion during PMN recruitment. However, the genetic absence 
of LRP1 on PMN did not affect the affinity regulation of LFA-1 
as measured by flow cytometry using LFA-1–specific intercellu-
lar adhesion molecule 1 (ICAM-1) binding (data not shown). We 
could exclude altered cell surface expression of β2 integrins in the 
absence of LRP1 as a cause of reduced PMN adhesion (Fig. S5 a).
MK specifically induces LRP1-mediated PMN trafficking
To investigate the functional impact of LRP1 on PMN traffick-
ing, we generated Hoxb8 stem cell factor (SCF) cells (referred 
to as Hoxb8 cells) from the bone marrow (BM) of LRP1ctrl 
(Hoxb8-LRP1ctrl) and LRP1cKO (Hoxb8-LRP1cKO) mice (Fig. S5 b). 
Hoxb8 cells were generated by immortalization of BM progen-
itor cells using transduction with estrogen-responsive Hoxb8, 
preventing the differentiation of progenitor cells. Upon removal 
of estrogen Hoxb8, cells can be differentiated toward PMNs in 
the presence of SCF (Wang et al., 2006; Redecke et al., 2013). 
These differentiated (d)Hoxb8 cells behave very similar com-
pared with BM-derived mPMNs and represent a useful tool to 
study PMN trafficking (Zehrer et al., 2018). Similar to freshly 
isolated PMNs, we found clustering and colocalization of LRP1 
and CD11a on adherent and migrating dHoxb8-LRP1ctrl in the 
presence of immobilized MK (iMK) under flow conditions using 
stimulated emission depletion (STED) nanoscopy (Fig. 5 a and 
Video 5). To study the functional impact of the MK–LRP1 axis, 
we analyzed adhesion of dHoxb8-LRP1ctrl and dHoxb8-LRP1cKO 
in microflow chambers in the presence of P-selectin, ICAM-1, 
and CXCL1 and found no difference between dHoxb8-LRP1ctrl 
and dHoxb8-LRP1cKO cells (Fig.  5  b). In sharp contrast, adhe-
sion of dHoxb8-LRP1cKO cells was significantly diminished 
in the presence of immobilized P-selectin, ICAM-1, and MK 
compared with dHoxb8-LRP1ctrl cells, indicating a role of the 
MK–LRP1 axis for PMN adhesion. Similarly, adhesion strength-
ening as well as spreading were specifically compromised in 
Representative confocal magnified image of NETs. Images show staining of DNA, NE, and H3Cit as well as the merged image, colocalization (coloc) of DNA/NE, 
and DNA/H3Cit as indicated. Bars, 10 µm. (e) Representative confocal images of cardiac sections of EAM mice at day 21 after induction of EAM and blockade 
of MK for 21 d. Images show staining of DNA, NE, and H3Cit as well as the merged image. Bars, 20 µm. (f–h) Histological analysis of extravasated PMN into 
the cardiac tissue at day 21 after induction of EAM without blocking MK (EAM + vehicle) or after application of an anti-N-MK blocking Ab (EAM + anti-N-MK). 
Diagrams show the number of extravasated PMNs per mm2 (f: vehicle, 768 ± 55 PMN/mm2; anti-N-MK, 158 ± 86 PMN/mm2), the number of NET+ PMNs per 
mm2 (g: vehicle, 40 ± 6 NET+ PMN; anti-N-MK = 5 ± 2 NET+ PMN), and the number of NET+ PMNs as a percentage of all extravasated PMNs (h: vehicle, 5.1 
± 0.5 NET+ PMN [%]; anti-N-MK, 0.9 ± 0.6 NET+ PMN [%]). n = 6 mice. To determine P values, ANO VA on ranks with Dunn’s multiple comparisons test was 
performed for c and d, and an unpaired Student's t test was used for f–h. For all panels, *, P < 0.05; **, P < 0.01; ***, P < 0.001. Data are presented as mean ± 
SEM or mean ± individual data points.
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dHoxb8-LRP1cKO compared with dHoxb8-LRP1ctrl cells in the 
presence of MK in contrast to CXCL1 (Fig. S5, c and d). Studying 
migration using dHoxb8 cells under flow conditions in vitro, 
the Euclidian distance and migration velocity on immobilized 
CXCL1 was not altered in the absence of LRP1. However, on iMK, 
the Euclidian distance and migration velocity were diminished 
in dHoxb8-LRP1cKO compared with control cells (Fig. 5, c and d; 
Fig. S5 e; and Video 6). Furthermore, in dHoxb8 cells generated 
from the BM of LRP1 NPxYxxL knock-in mice (dHoxb8-LRP1-
NPxYki) with a nonfunctional membrane distal intracellular 
NPxY domain, adhesion was significantly reduced compared 
with control cells (dHoxb8-LRP1-NPxYctrl), suggesting that the 
membrane distal NPxY domain of LRP1 is involved in MK-medi-
ated adhesion (Fig. 5 e).
Figure 2. Targeting MK attenuates leuko-
cyte infiltration into the heart during EAM. 
(a and b) Semiquantitative histological analysis 
of leukocyte infiltration (a) and evaluation of the 
heart/body weight ratio (b) at day 21 after sham 
immunization (sham: a, mean EAM score, 0.2 ± 
0.1; b, mean heart/body weight ratio, 0.56 ± 0.01) 
or induction of EAM. EAM mice were treated with 
an anti-N-MK blocking Ab (EAM + anti-N-MK: 
a, mean EAM score, 1.4 ± 0.27; b, mean heart/
body weight ratio, 0.64 ± 0.03) or vehicle alone 
(EAM + vehicle: a, mean EAM score, 2.5 ± 0.26; 
b, mean heart/body weight ratio, 0.74 ± 0.02) 
as depicted. n = 10 for sham group; n = 25 for 
EAM groups. (c and d) Flow cytometric analysis 
of leukocyte subpopulations in the cardiac tissue 
on day 21 after induction of EAM. Diagrams show 
the percentage of leukocyte subpopulations of all 
cells after blocking the N-terminal domain (EAM 
+ anti-N-MK, c; CD45+: isotype ctrl, 5.28 ± 0.76 
cells [%], anti-N-MK, 2.12 ± 0.42 cells [%]; CD45+/
CD11b+/Gr-1+: isotype ctrl, 1.59 ± 0.58 cells [%], 
anti-N-MK, 0.45 ± 0.08 cells [%]; Ly6G+: isotype 
ctrl, 1.74 ± 0.39 cells [%], anti-N-MK, 0.99 ± 0.28 
cells [%]; CD45+/CD11b+/Gr-1−: isotype ctrl, 1.84 
± 0.41 cells [%], anti-N-MK, 1.37 ± 0.29 cells [%]; 
CD4+: isotype ctrl, 1.86 ± 0.23 cells [%], anti-
N-MK, 1.02 ± 0.07 cells [%]) or the C-terminal 
domain of MK (EAM + anti-C-MK, d; CD45+: iso-
type ctrl, 4.86 ± 0.72 cells [%], anti-C-MK, 5.29 ± 
0.86 cells [%]; CD45+/CD11b+/Gr-1+: isotype ctrl, 
1.47 ± 0.51 cells [%], anti-C-MK, 1.28 ± 0.31 cells 
[%]; CD45+/CD11b+/Gr-1−: isotype ctrl, 1.61 ± 0.25 
cells [%], anti-C-MK, 1.86 ± 0.30 cells [%]; CD4+: 
isotype ctrl, 1.50 ± 0.12 cells [%], anti-C-MK, 1.41 
± 0.15 cells [%]) compared with the matching 
isotype controls (EAM + isotype ctrl). n = 18. (e) 
Representative immunofluorescence images of 
cardiac sections of sham-treated mice for con-
trol (top) or EAM mice at day 21 after induction 
of EAM (bottom). Images show staining of CD31, 
MK, and DAPI as well as the merged image. 
Arrows indicate a blood vessel. Arrowheads show 
MK expression in the perivascular compartment. 
Bars, 100 µm. To determine P values, ANO VA on 
ranks with Dunn’s multiple comparisons test was 
performed for a and b, and a Mann-Whitney rank 
sum test was used for c and d. For all panels, *, 
P < 0.05; **, P < 0.01; ***, P < 0.001; n.s., not 
significant. Data are presented as mean ± SEM 
or mean ± individual data points.
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MK promotes NET formation via LRP1
As the blockade of MK was able to reduce NET formation in the 
EAM model in vivo, we investigated whether MK was able to in-
duce NET formation. Indeed, iMK substantially promoted forma-
tion of NETs of mPMNs in contrast to the unstimulated control 
(w/o) or after stimulation with soluble MK (sMK) as indicated by 
the presence of H3Cit (Fig. 6 a). We repeated these experiments 
with isolated human PMNs that were stimulated in the presence 
Figure 3. Blocking MK reduces cardiac fibrosis and preserves cardiac function during the chronic phase of myocarditis. (a) Representative cross sections 
of cardiac tissue of sham-treated control mice, vehicle-treated EAM mice, and EAM mice after anti-N-MK Ab treatment on day 63 using Masson’s trichrome 
staining. Fibrotic tissue appears blue. Bars, 1 mm (overview); 100 µm (magnification). (b) Degree of fibrosis in the cardiac tissue using a semiquantitative score. 
Single data points represent individual mice (sham: mean fibrosis score, 0 ± 0; EAM + vehicle: mean fibrosis score, 1.68 ± 0.32; EAM + anti-N-MK: mean fibrosis 
score, 0.80 ± 0.22). n = 10 for sham mice; n = 25 for EAM groups. (c) Echocardiographic images on day 63 after immunization. Representative M-mode short axis 
view images depicting diastolic and systolic diameters of vehicle-treated animals (EAM + vehicle) as well as anti-N-MK Ab–treated mice (EAM + anti-N-MK). (d 
and e) Parameters describing systolic function using (d) fractional shortening (sham, 32.1 ± 1.0 [%]; EAM + vehicle, 24.4 ± 1.1 [%]; EAM + anti-N-MK, 27.9 ± 1.0 
[%]) and (e) left ventricular ejection fraction (sham, 60.8 ± 1.4 [%]; EAM + vehicle, 48.6 ± 1.9 [%]; EAM + anti-N-MK, 54.2 ± 1.5 [%]). n = 10 for sham mice; n = 25 
for the EAM groups. (f–i) Intravital microscopy of cremaster muscle postcapillary venules of WT mice treated with anti–N-MK blocking Ab (anti-N-MK) or the 
appropriate isotype Ab (isotype ctrl) as control 2 h after intrascrotal application of TNFα. n = 15 venules from four mice (isotype ctrl); n = 17 venules from four mice 
(anti-N-MK). (f) Leukocyte rolling flux fraction (isotype control, 0.047 ± 0.013 [%]; anti-N-MK, 0.048 ± 0.019 [%]). (g) Leukocyte rolling velocity including 35 cells 
from four control mice (isotype ctrl) and 41 cells from four mice after blocking MK (anti-N-MK; isotype ctrl, 2.47 ± 0.18 µm/s; anti-N-MK, 3.32 ± 0.25 µm/s). (h) 
Number of adherent leukocytes per mm2 (isotype control, 490.6 ± 48.8 cells/mm2; anti-N-MK, 259.8 ± 51.2 cells/mm2). (i) Hemodynamic parameters of inves-
tigated vessels. To determine P values, ANO VA on ranks with Dunn’s multiple comparisons test was performed for b, d, and e, and an unpaired Student's t test 
was used for f–h. For all panels, *, P < 0.05; **, P < 0.01; ***, P < 0.001; n.s., not significant. Data are presented as mean ± SEM or mean ± individual data points.
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Figure 4. The MK receptor LRP1 is critical for leukocyte recruitment. (a–d) Intravital microscopy of cremaster muscle postcapillary venules of LRP1ctrl and 
LRP1cKO mice 2 h after intrascrotal application of TNFα. n = 18 venules from four LRP1ctrl mice, n = 14 venules from three LRP1cKO mice. (a) Leukocyte rolling 
flux fraction (LRP1ctrl, 0.097 ± 0.020 [%]; LRP1cKO, 0.104 ± 0.032 [%]). (b) Leukocyte rolling velocity including 79 cells from four LRP1ctrl mice and 71 cells from 
three LRP1cKO mice (LRP1ctrl, 6.74 ± 0.24 µm/s; LRP1cKO, 6.66 ± 0.17 µm/s). (c) Number of adherent leukocytes per mm2 (LRP1ctrl, 1122.2 ± 133.2 cells/mm2; 
LRP1cKO, 456.0 ± 60.6 cells/mm2). (d) Hemodynamic parameters of investigated vessels. (e) Differential cell counts of perivascular leukocytes as analyzed 
histologically in cremaster muscle whole mounts after Giemsa staining 2 h after intrascrotal application of TNFα. Eos, eosinophils; Others, lymphocytes, 
basophils and monocytes; n = 47 venules from four LRP1ctrl mice, n = 28 from three LRP1cKO mice (PMN: LRP1ctrl, 958.3 ± 75.2 cells/mm2, LRP1cKO, 354.1 ± 65 
cells/mm2). (f–h) Flow chamber assays with mPMN using spinning disk confocal microscopy after coating with P-selectin, ICAM-1, and CXCL1. (f) The intensity 
of LRP1 and CD11a as well as LRP1 and Gr-1 expression together with the merged (merge) or colocalized (coloc) intensity of one single representative cell is 
depicted during rolling and adhesion. Arrows indicate direction of flow. Right panels demonstrate the intensity of LRP1 and CD11a cell surface expression 
using pseudocolors (heat map). (g) Analysis of the intensity per area of colocalization of LRP1 or CD11a as well as of LRP1 or Gr-1, kinetics of rolling velocity 
and correlation of colocalization during rolling and adhesion of one representative cell. (h) Mean intensity per area of colocalization of LRP1 and CD11a (rolling, 
0.071 ± 0.009 arbitrary units [a.u.]; adhesion, 0.255 ± 0.033 a.u.) as well as of LRP1 and Gr-1 (rolling, 0.280 ± 0.042 a.u.; adhesion, 0.299 ± 0.037 a.u.) during 
rolling and adhesion. LRP1/CD11a: n = 23 cells/five experiments, LRP1/Gr-1: n = 11 cells/three experiments. To determine P values, an unpaired Student's t 
test was performed for a–c and h, and ANO VA on ranks with Dunn’s multiple comparisons test was used for e. For all panels, *, P < 0.05; **, P < 0.01; n.s., not 
significant. Data are presented as mean ± SEM.
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Figure 5. LRP1-mediated PMN recruitment is MK dependent. (a) Representative images of dHoxb8-LRP1ctrl cells on microflow chambers coated with 
recombinant P-selectin, ICAM-1, and MK. Cells were perfused through chambers with a shear rate of 1 dyne/cm2. Staining of cells was conducted using specific 
anti-LRP1 and anti-CD11a Abs, and imaging was performed using STED nanoscopy. Images show expression of LRP1 (green), CD11a (red), merge (yellow), and 
colocalization (coloc; pseudocolors [heat map]) of LRP1 and CD11a. The top panel illustrates an adherent cell and the lower panel a migrating cell. (b) Induc-
tion of adhesion of dHoxb8-LRP1ctrl and dHoxb8-LRP1cKO cells under flow conditions (1 dyne/cm2) in microflow chambers coated with immobilized P-selectin, 
ICAM-1, and CXCL1 (dHoxb8-LRP1ctrl, 100.0 [%]; dHoxb8-LRP1cKO, 95.1 ± 12.7 [%]) or MK (dHoxb8-LRP1ctrl, 100.0 [%]; dHoxb8-LRP1cKO, 40.8 ± 6.0 [%]) as 
indicated. n = 4. (c and d) Migration of dHoxb8 cells under flow conditions. Euclidean distance (c; CXCL1: dHoxb8-LRP1ctrl, 11.4 ± 2.2 µm; dHoxb8-LRP1cKO, 
9.4 ± 1.6 µm; MK: dHoxb8-LRP1ctrl, 11.6 ± 0.55 µm; dHoxb8-LRP1cKO, 6.56 ± 0.65 µm) as well as migration velocity (d; CXCL1: dHoxb8-LRP1ctrl, 2.47 ± 0.25 
µm/min; dHoxb8-LRP1cKO, 2.41 ± 0.26 µm/min; MK: dHoxb8-LRP1ctrl, 2.56 ± 0.16 µm/min; dHoxb8-LRP1cKO, 1.54 ± 0.08 µm/min) of dHoxb8-LRP1ctrl (white 
bar) and dHoxb8-LRP1cKO (black bar) under flow conditions (1 dyne/cm2). Flow chambers were coated with P-selectin, ICAM-1, and CXCL1 or MK as indicated. 
dHoxb8-LRP1ctrl cells on CXCL1: n = 3 experiments/214 cells; dHoxb8-LRP1cKO cells on CXCL1: n = 3 experiments/303 cells. dHoxb8-LRP1ctrl cells on MK: n = 4 
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of sMK, iMK, or PMA or left untreated for control (w/o). In con-
trast to sMK or the unstimulated control, we observed substan-
tial NET formation in the presence of iMK and PMA (Fig. 6 b), 
as indicated by the colocalization of DNA and MPO. To elucidate 
whether LRP1 was involved in MK-mediated NETosis, we stud-
ied NET formation in the presence of MK using dHoxb8-LRP1ctrl 
or dHoxb8-LRP1cKO cells (Fig. 6 c). PMA induced NET formation 
regardless of the presence of LRP1, whereas almost no NET for-
mation was observed in the negative control. We also found NET 
formation in dHoxb8-LRP1ctrl cells on iMK. However, NET forma-
tion was significantly reduced in dHoxb8-LRP1cKO cells compared 
with dHoxb8-LRP1ctrl cells in the presence of iMK (Fig. 6 d), sug-
gesting that MK promotes NET formation via LRP1.
Discussion
In the past three decades, research on the pathogenesis of myo-
carditis has been focused on the impact of adaptive immunity, 
whereas the role of PMNs as classical drivers of innate immunity 
has only been marginally addressed. Here, we demonstrate the 
presence of NETs in EMBs of patients with active myocarditis. 
To our knowledge, this is the first description of NETs in human 
myocardial tissue.
Although initial triggers differ in human myocarditis com-
pared with EAM, sustained inflammation of the myocardium 
by a subsequent autoimmune response mediated by CD4+ T cells 
generally represents the common feature of chronic myocardi-
tis regardless of the trigger (Rose, 2014). The fact that depletion 
of CD4+ T cells completely prevented EAM in mice (Smith and 
Allen, 1991) led to the concept that myocarditis is a T cell–medi-
ated disease (Afanasyeva et al., 2004b). We found that disease 
severity could be substantially reduced by targeting NETs, sug-
gesting a putative connection between the T cell response and 
NETosis. Indeed, a direct link of NETs and CD4+ T cells has been 
demonstrated as NETs were able to reduce the threshold for CD4+ 
T cell activation (Tillack et al., 2012). This interplay may explain 
that blocking either NETs or CD4+ T cells profoundly diminished 
cardiac inflammation in EAM (Afanasyeva et al., 2001, 2004a,b).
In our study, blockade of the cytokine MK substantially re-
duced PMN infiltration into the inflamed cardiac tissue in 
EAM. This is in line with our previous findings in the inflamed 
cremaster muscle, where diminished leukocyte adhesion and 
subsequent infiltration were observed in MK-deficient mice 
(Weckbach et al., 2014). Surprisingly, in the EAM model, not only 
the absolute number of NET+ PMNs was reduced after inhibition 
of MK but also the relative number of NET+ PMNs as a percent-
age of all extravasated PMNs. These findings may point to a dual 
function of MK by promoting the recruitment of PMNs as well as 
the formation of NETs. Indeed, MK was able to induce NETosis of 
isolated human and murine PMNs as well as dHoxb8 cells in vitro. 
In accordance with our previous work, showing that immobili-
zation of MK was required to mediate PMN adhesion (Weckbach 
et al., 2014), only iMK, but not sMK, was able to induce NETosis. 
Whether this is due to orientation of the MK molecule, for exam-
ple, or a matter of protein clustering remains elusive.
MK consists of two domains, a C-terminal and an N-terminal 
domain, which exert different functions (Muramatsu, 2014). The 
fact that the Ab directed against the N-terminal domain of MK, 
but not the Ab directed against the C-terminal domain, blocked 
leukocyte infiltration in EAM suggests that the N-terminal do-
main is specifically required for the observed effects. Accord-
ingly, the N-terminal domain has been shown to be particularly 
relevant for the stabilization of the protein via dimerization 
(Kojima et al., 1997; Muramatsu, 2014). This could potentially ex-
plain why the anti-N-MK Ab, but not the anti-C-MK Ab, inhibited 
leukocyte infiltration in EAM. Another possible explanation is 
the blockade of the specific interaction of the proposed recep-
tor LRP1 with the N-terminal MK domain by the anti-N-MK Ab. 
However, to our knowledge, at this point, it is still unclear which 
MK domain binds LRP1.
The exact mechanism by which MK promotes the recruit-
ment of PMNs and NETosis during myocarditis in vivo remains 
partially unclear. There is evidence that MK binds to the glyco-
calyx of the endothelium via its heparin-binding sites in vivo 
(Novotny et al., 1993). Inflammatory conditions such as hypoxia 
lead to up-regulation and release of MK from endothelial cells 
(Weckbach et al., 2012). Increased expression and presentation 
of iMK on the endothelial surface interacting with PMNs may 
therefore promote their infiltration during myocarditis. Due to a 
delay between the initial trigger and development of NETs from 
minutes to hours, depending on the stimulus (Jorch and Kubes, 
2017), PMNs may undergo MK-mediated NETosis after infiltra-
tion in the cardiac tissue. Although MK was able to mediate NET 
formation in vitro, a contribution of other proinflammatory 
mediators to NET formation is possible in the complex scenario 
of the inflamed heart. Moreover, blocking MK not only reduced 
PMN but also reduced CD4+ T cell infiltration. Whether the re-
duction of PMN/NETs subsequently resulted in decreased CD4+ 
T cell recruitment in our model or whether MK directly mediated 
the recruitment of CD4+ T cells remains unclear and requires fur-
ther investigation. In fact, we found expression of MK in the peri-
vascular compartment of the inflamed cardiac tissue, supporting 
the idea of a direct involvement of MK in the leukocyte recruit-
ment process (Stark et al., 2013). However, the exact source and 
localization of MK in vivo under steady state and inflammatory 
conditions need to be clarified in further studies.
In a mouse model of ascending aortic constriction mimick-
ing aortic stenosis and leading to pressure overload–mediated 
heart dysfunction, NETs acted as major drivers of cardiac fibro-
sis (Martinod et al., 2017). Accordingly, collagen deposition was 
experiments/280 cells; dHoxb8-LRP1cKO cells on MK: n = 4 experiments/197 cells. (e) Induction of adhesion of dHoxb8-LRP1-NPxYctrl and dHoxb8-LRP1-NPxYki 
cells under flow conditions (1 dyne/cm2) in microflow chambers coated with immobilized P-selectin, ICAM-1, and CXCL1 (top diagram; dHoxb8-LRP1-NPxYctrl, 
929.9 ± 62.9 cells; dHoxb8-LRP1-NPxYki, 762.8 ± 83.7 cells) or MK (bottom diagram; dHoxb8-LRP1-NPxYctrl, 953.3 ± 74.2 cells; dHoxb8-LRP1-NPxYki, 647.3 ± 
101.8 cells). n = 6. To determine P values, an unpaired Student's t test was performed. For all panels, *, P < 0.05; **, P < 0.01; ***, P < 0.001; n.s., not significant. 
Data are presented as mean ± SEM.
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Figure 6. MK induces NET formation via LRP1. (a) Representative immunofluorescence images of BM-derived isolated mPMN. Cells were exposed to 
sMK, iMK, PMA or left untreated for control (w/o) on murine fibrinogen for 16 h. DNA (white) and H3Cit (magenta). Arrows indicate NETs. Bar, 40 µm. n = 3. 
(b) Images of human PMNs freshly isolated from healthy donors. Cells were stimulated in the presence of human fibrinogen with sMK, iMK, or PMA or left 
unstimulated for control (w/o). Staining for DNA (white) and MPO (green) was subsequently conducted. n = 3. (c) Representative immunofluorescence images of 
dHoxb8-LRP1ctrl or dHoxb8-LRP1cKO cells. Cells were stimulated in the presence of iMK, PMA, or left unstimulated for control (w/o). Staining for DNA (white) and 
H3Cit (magenta) is depicted as indicated. Bar, 40 µm. n = 3. (d) Quantitative analysis of NET formation of dHoxb8-LRP1ctrl or dHoxb8-LRP1cKO in the presence 
D
ow
nloaded from
 https://rupress.org/jem
/article-pdf/216/2/350/761174/jem
_20181102.pdf by U
niversity of Zurich user on 21 January 2020
Weckbach et al. 
Midkine drives cardiac inflammation
Journal of Experimental Medicine
https://doi.org/10.1084/jem.20181102
361
markedly reduced and systolic function was preserved in PAD4−/− 
mice or after administration of DNase in this model. In our study, 
we observed reduced fibrosis after blocking MK. The fact that 
neutralizing MK during the acute phase of myocarditis mainly 
impaired PMN and CD4+ T cell infiltration as well as NETosis sup-
ports the idea that PMNs forming NETs are major drivers of car-
diac fibrosis in this model. Whether MK fosters fibrosis directly 
or indirectly by promoting inflammation remains unclear. Inter-
estingly, Zhang et al. (2015) demonstrated that a pathway involv-
ing Nox1, MK, Notch2, and the angiotensin-converting enzyme 
contributed to lung remodeling and fibrosis. However, a direct 
contribution of MK to cardiac fibrosis remains to be determined.
Our data indicate a detrimental role of MK in cardiac inflam-
mation. In contrast, animal models of myocardial infarction have 
shown a protective role of MK for the injured cardiac tissue by 
preventing apoptosis and mediating angiogenesis (Takenaka et 
al., 2009; Sumida et al., 2010). Here, PMN infiltration, although 
mostly considered to be detrimental (Epelman et al., 2015), 
may also have beneficial effects for post–myocardial infarc-
tion healing (e.g., by polarizing macrophages toward a repara-
tive phenotype; Horckmans et al., 2017). Thus, MK may have a 
protective effect by mediating PMN recruitment in myocardial 
infarction models. Nonetheless, most studies investigating MK 
under chronic inflammatory conditions have clearly indicated a 
harmful role of MK for the host (Maruyama et al., 2004; Wang et 
al., 2008). Moreover, overexpression of MK promoted pressure 
overload–induced cardiac remodeling and cardiac dysfunction 
(Netsu et al., 2014). Thus, a beneficial or detrimental effect of 
MK during cardiac inflammation may depend on the mechanism 
of cardiac injury.
MK has been shown to function as ligand for LRP1 on different 
cell types (Lillis et al., 2008), and binding of MK to PMN was 
compromised after blocking LRP1 (Weckbach et al., 2014). Sim-
ilar to the data in MK−/− mice (Weckbach et al., 2014), leukocyte 
adhesion and extravasation were substantially diminished in the 
absence of LRP1 in our study, indicating that LRP1 is critically 
involved in mediating adhesion. Inhibiting LRP1 with RAP, which 
blocks all members of the LDL receptor family, reduced leuko-
cyte infiltration during EAM. However, we cannot exclude that 
the blockade of LDL receptor family members other than LRP1 
contributed to our findings. Whether MK acts by engaging LRP1 
in vivo still needs to be determined. Other groups have shown 
that LRP1 was able to interact with the β2 integrins LFA-1 and 
the macrophage-1 antigen (CD11b/CD18; Spijkers et al., 2005; 
Ranganathan et al., 2011), which are critical for adhesion, spread-
ing, and intraluminal crawling of PMN during the recruitment 
process (Ley et al., 2007). Spijkers et al. (2005) demonstrated 
that LRP1 was important for adhesion of the monocyte-like cell 
line U937 on isolated endothelial cells under flow conditions by 
being involved in CD11a clustering. Accordingly, we found a clear 
colocalization and clustering of LRP1 and CD11a on PMN when 
the cells became adherent, cumulating in a concentrated area of 
LRP1 and CD11a expression, which potentially represents the ad-
hesion site where cells interacted with the adhesive substratum.
Whereas clustering and colocalization of LRP1 and CD11a were 
not dependent on MK but also occurred in the presence of CXCL1, 
adhesion of dHoxb8-LRP1cKO cells was only compromised in the 
presence of MK. In contrast, CXCL1-induced adhesion did not 
rely on LRP1, suggesting that MK-mediated adhesion was LRP1 
dependent. Accordingly, spreading and intraluminal crawling 
were diminished in dHoxb8-LRP1cKO cells exposed to iMK, but 
not to immobilized CXCL1. These findings imply that MK is not 
required to initiate LFA-1 clustering but may enhance adhesion 
by β2 integrins via LRP1. Here, the membrane distal NPxY do-
main of LRP1 seems to be involved in MK-mediated adhesion. 
Similar to PMN adhesion, MK-mediated NET formation was de-
pendent on LRP1 in vitro, suggesting an important role of LRP1 
for MK-mediated PMN functions.
In conclusion, our results identify a novel and important role 
of PMN and NETs in myocarditis. We provide evidence that NETs 
are detrimental for the host during myocarditis. In addition, we 
propose the model that the cytokine MK promotes PMN infiltra-
tion into the myocardium and may contribute to NET formation 
via LRP1 in this context. To date, there is no established therapy 
for patients with chronic inflammatory cardiomyopathy other 
than nonspecific immunosuppression with limited benefits 
and severe side effects. Therefore, blocking MK or NETs could 
represent novel and promising therapeutic options for patients 
with myocarditis.
Materials and methods
Human samples
The study was conducted according to the Declaration of Hel-
sinki and approved by the Ethics Committee of the University 
of Munich. Human whole blood was drawn from healthy volun-
teers. Paraffin-embedded EMBs from patients with myocarditis 
were retrospectively analyzed. Clinical data of patients were ob-
tained from medical records. The necessity for informed consent 
was waived by the local ethics committee due to the retrospective 
nature of the study.
Mice
LRP1fl/fl mice on a 129S7/SvEvBrd genetic background were ob-
tained from The Jackson Laboratory. LRP1fl/fl mice were crossed 
with vav1-cre mice maintained on a C57Bl/6 background to gen-
erate LRP1fl/fl/vav-cre+ (LRP1cKO) and LRP1fl/fl/vav-cre− (LRP1ctrl) 
animals as controls. For experiments, only littermates were used 
as controls. For the EAM model, 8-wk-old male WT mice on a 
BALB/c background were purchased from Charles River. CD4+ 
T cell proliferation assays were conducted in 8-wk-old BALB/c 
WT mice. For the cremaster muscle model using the anti-N-MK 
of iMK (dHoxb8-LRP1ctrl, 21.3 ± 1.9 NET+ cells [%]; dHoxb8-LRP1cKO, 5.12 ± 1.7 NET+ cells [%]), PMA (dHoxb8-LRP1ctrl, 51.1 ± 2.7 NET+ cells [%]; dHoxb8-LRP1cKO, 
50.9 ± 3.6 NET+ cells [%]), or without simulation (dHoxb8-LRP1ctrl, 6.2 ± 1.4 NET+ cells [%]; dHoxb8-LRP1cKO, 3.2 ± 0.6 NET+ cells [%]). Data show the number 
of NET+ cells as a percentage of all dHoxb8 cells. n = 3. To determine P values, one-way ANO VA with Holm–Sidak multiple comparisons test was performed. 
***, P < 0.001. Data are presented as mean ± SEM.
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blocking Ab, 8–12-wk-old C57Bl/6 WT mice were used. Animals 
were fed a standard chow diet ad libitum with free access to 
water. All animal experiments were institutionally approved by 
the Regierung von Oberbayern, Germany.
Isolation of human PMNs
Isolation was performed with a discontinuous isotonic Percoll 
gradient as previously described (Willeke et al., 2000). Human 
PMNs were subsequently resuspended in adhesion medium 
(HBSS; L0605; Biowest) supplemented with 20  mM Hepes 
(9105; Roth), 0.25% BSA (9306; Sigma-Aldrich), 0.1% glucose 
(7509; Roth), 1.2 mM Ca2+ (CN93; Roth), and 1 mM Mg2+ (9453; 
Roth). Human PMN viability as evaluated by a trypan blue ex-
clusion test was >99%.
Isolation of murine PMNs
PMNs were isolated from murine BM of LRP1ctrl and LRP1cKO mice 
using a discontinuous Percoll gradient as described previously 
(Pick et al., 2017). Isolated PMNs were cultivated for 24 h in RPMI 
1640 medium (R8758; Sigma-Aldrich), supplemented with 20% 
WEHI-3B–conditioned medium at 37°C and 5% CO2. Murine PMN 
viability as evaluated by a trypan blue exclusion test was >95%.
Generation of Hoxb8-SCF cells
Hoxb8-SCF cells (referred to as Hoxb8 cells) were generated and 
differentiated toward PMNs as previously described (Wang et 
al., 2006; Redecke et al., 2013). HEK293T cells were transfected 
with the retroviral backbone pMSCVneo-ER-Hoxb8 and the eco-
tropic packaging vector pCL-Eco by Lipofectamine 2000 (116688; 
Thermo Fisher). The plasmids were a gift from Hans Häcker (St. 
Jude Children’s Research Hospital, Memphis, TN). After 48  h, 
virus was harvested. BM cells of 8–10-wk-old mice were isolated, 
and progenitor cells were enriched by centrifugation over a HIS 
TOP AQUE 1083 (10831; Sigma-Aldrich) gradient. Progenitor cells 
were stimulated to proliferate in stem cell medium (RPMI 1640 
plus 15% FCS [F2442; Sigma-Aldrich]; 1% penicillin/streptomycin 
[P4333, Merck]; 10 ng/ml murine IL-3 [213–13; Peprotech]; 20 ng/
ml murine IL-6 [216–16; Peprotech]; and 2% SCF containing su-
pernatant) for 3 d. For the generation of Hoxb8 cells, stimulated 
progenitor cells were transduced with the retrovirus by spinocu-
lation with Lipofectamine (116688; Thermo Fisher) at 1,500 g for 
80 min in progenitor outgrowth medium containing 1 µM β-es-
tradiol (2758; Sigma-Aldrich), 30 µM β-mercaptoethanol (A1108; 
PanReac AppliChem), and 2% SCF containing supernatant. Every 
3 d, cells were split into fresh progenitor outgrowth medium. 
After 4 wk, a Hoxb8 cell line was established. For differentia-
tion of Hoxb8 cells toward PMN, 2.5 × 105 cells were washed in 
PBS with 1% FCS and taken up in differentiation medium (RPMI 
1640 plus 10% FCS, 1% penicillin/streptomycin, 20 ng/ml murine 
G-CSF [250–05; Peprotech]; 2% SCF-containing supernatant, 
30 µM β-mercaptoethanol) and allowed to differentiate for 4 d. 
Hoxb8 cells were generated from the BM of LRP1cKO and LRP1-
NPxYki mice as well as their matching controls.
EAM model
For induction of EAM, the purified synthetic peptide of cardiac 
α myosin heavy chain (Ac-RSL KLM ATL FST YAS ADR) emulsi-
fied in CFA (F5881; Sigma-Aldrich) was administered s.c. (200 
µg of cardiac peptide per mouse) at day 1 and day 7. For sham 
controls, equal volumes of CFA and PBS were injected. To block 
MK, a mouse anti-human N-MK Ab (clone IP10, Cellmid; iso-
type: mouse IgG1, 401407, RRID: AB _11148722; BioLegend) or 
a mouse anti-human C-MK Ab (clone IP14, Cellmid; isotype: 
mouse IgG2a, 400264, RRID: AB _11148947; BioLegend) were ap-
plied i.p. (10 µg/g body weight) twice a week until day 21. To 
investigate the role of NET formation during EAM, mice were 
treated with DNase (50 µg i.p. per mouse twice daily, Dornase α; 
Roche) or Cl-amid (250 µg N-α-benzoyl-N5-(2-chloro-1-imino-
ethyl)-L-ornithine amide) s.c. per mouse daily (506282; Merck) 
from day 1 until day 21. Accordingly, sham controls and vehicle 
controls were treated with PBS. To study the impact of LRP1 on 
leukocyte infiltration, we implanted miniosmotic pumps (model 
2004; Alzet) s.c., which were filled with chemically modified 
stable RAP (Prasad et al., 2015). Lyophilized RAP dissolved in 
PBS at a concentration of 112 µM or PBS as a control were re-
leased from miniosmotic pumps at a constant rate (0.25 µl/h), 
achieving RAP plasma levels of 5–10 nM (Strickland, D., personal 
communication). On day 21, mice were sacrificed and hearts 
were harvested for analysis.
Histology and heart/body weight ratio
For histopathological evaluation of cardiac tissue, mouse hearts 
were rinsed with PBS and fixed in PFA 4% (CP10; Roth) for at 
least 24 h. For analysis of the heart/body weight ratio, the peri-
cardium, connective tissue, and vascular remains were excised 
carefully before hearts were weighed using a microbalance 
(CP64-0CE; Sartorius). Subsequently, hearts were dehydrated 
in a graded series of ethanol concentrations. Thereafter, tissues 
were embedded in paraffin (1.07158; Sigma-Aldrich). Murine 
sections were stained with hematoxylin (T865.1; Roth) and eosin 
(X883.1, day 21; Roth) to evaluate infiltration of hematopoietic 
cells or with Masson’s trichrome (010802, day 63; Bio-Optica) 
to assess cardiac fibrosis. Acute infiltration was evaluated semi-
quantitatively using an EAM score (0, no inflammatory infil-
trates; 1, small foci of <100 inflammatory cells between myocytes; 
2, larger foci of >100 inflammatory cells; 3, >10% of a cross sec-
tion shows infiltration of inflammatory cells; 4, >30% of a cross 
section shows infiltration of inflammatory cells) as previously 
described (Valaperti et al., 2008). To assess fibrosis by morpho-
metric evaluation, ∼30 fields per section were chosen randomly. 
Fibrosis was evaluated using a semiquantitative score (0, 0–1%; 1, 
1–2%; 2, 2–3%; 3, 3–4%; 4, 4–5%; 5, >5% fibrosis). All analyses were 
performed in a blinded manner.
Echocardiography
Transthoracic echocardiography was conducted using a Vevo2100 
imaging system (VisualSonics) with a 40-MHz transducer at day 
63. Anesthesia was performed with 2% isoflurane. To ensure a 
stable body temperature of 35.5–36.5°C, mice were transferred 
to a heated platform. Parasternal long-axis M-mode was used 
to standardize midventricular transducer positioning for short-
axis M-mode imaging as previously described (Grabmaier et al., 
2014). For evaluation of cardiac function, three consecutive cy-
cles were measured and averaged.
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NET induction
For NETosis experiments, in vitro 8-well slides (IBI DI) were 
coated with human or murine fibrinogen (100 µg/ml; IFIB; 
Dunn) or human or murine MK (20 µg/ml; 450–16; Peprotech) 
for 12 h at 4°C before the experiment. After washing wells with 
PBS, 3 × 105 PMNs suspended in adhesion medium (HBSS sup-
plemented with 20 mM Hepes, 0.25% BSA, 0.1% glucose, 1.2 mM 
Ca2+, and 1.0 mM Mg2+) were added. Human PMNs were incu-
bated and stimulated for 1 h, whereas mPMNs or Hoxb8 cells 
were stimulated for 16 h at 37°C. PMNs or Hoxb8 cells were stim-
ulated with PMA (100 nM) in the presence of fibrinogen as a 
positive control.
Laser scanning confocal microscopy
To study NET formation in vitro, adherent PMNs were fixated 
with PFA 4% for 10 min. After blocking (PBS, goat serum 10%; 
G9023, BSA 1%; Sigma-Aldrich) for 2 h, primary Abs were added 
(human: rabbit-anti-human MPO Ab, clone SP72, ab93665; 
Abcam; murine: rabbit anti-mouse H3Cit Ab, polyclonal, ab5103; 
Abcam; rat–anti-mouse NE/mELA2 Ab: clone 887105, MAB4517; 
R&D Systems) and incubated for 90 min at room temperature 
(RT) in the dark. Subsequently, samples were washed and in-
cubated with secondary Abs for 30 min (human: Alexa Fluor 
488–conjugated goat-anti-mouse Ab, A21042; Thermo Fisher; 
murine: Alexa Fluor 488–conjugated goat anti-rat Ab, A11006; 
Thermo Fisher; and Alexa Fluor 546 goat anti-rabbit Ab, A11035; 
Abcam). Nuclear staining was performed using Hoechst 33342 
(624249; Thermo Fisher) diluted 1:1,000 in human and murine 
experiments. Finally, samples were embedded using fluores-
cence mounting medium (S3023; DAKO). To quantify NET for-
mation, the number of NET+ dHoxb8 cells as a percentage of all 
dHoxb8 cells per visual field was calculated. For each experi-
ment, five fields per sample were randomly imaged and analyzed 
offline in a blinded manner. Confocal microscopy was conducted 
using a Leica SP8X WLL upright confocal microscope equipped 
with a 40×/1.3 NA oil immersion objective. Alexa Fluor 488 and 
Alexa Fluor 546 were recorded with hybrid photo detectors and 
Hoechst with a conventional multiplier tube. Images were ana-
lyzed offline using LAS X software (Leica) and ImageJ (National 
Institutes of Health).
To analyze NET formation in murine heart sections, samples 
were deparaffinized, rehydrated, and incubated in citrate buf-
fer (1.5 mM citrate monohydrate [5110; Roth]; and 8.5 mM so-
dium citrate dihydrate [4088; Roth], adjusted to pH 6.0) at 100°C 
for 7 min for antigen retrieval. Subsequently, sections were left 
in citrate buffer at RT to cool below 30°C. To prevent nonspe-
cific binding, sections were surrounded with PAP pen (S2002; 
DAKO) and incubated with blocking solution (PBS, goat serum 
10%, BSA 1%, saponin 0.5% [47036; Sigma-Aldrich]) for 90 min at 
RT. Primary Abs (rat anti-mouse NE Ab, clone 887105 [MAB4517; 
R&D Systems]; rabbit anti-mouse H3Cit Ab, polyclonal [ab5103; 
Abcam]) were diluted 1:200 in blocking solution and incubated 
with the samples for 2 h at RT. After washing, sections were in-
cubated with secondary Abs (Alexa Fluor 488–conjugated goat-
anti-rat Ab [ab150157; Abcam]; Alexa Fluor 594-conjugated 
goat-anti-rabbit Ab [A11012; Thermo Fisher]) for 30 min at RT. 
For nuclear staining, Hoechst 33342 (624249; Thermo Fisher) 
was diluted 1:1,000 together with secondary Abs in PBS/BSA 1% 
solution. Thereafter, samples were embedded using fluorescence 
mounting medium (S3023; DAKO). Confocal microscopy was 
conducted using a Leica SP8X WLL upright confocal microscope 
equipped with a 40×/1.3 NA oil-immersion objective. Alexa Fluor 
488 and Alexa Fluor 594 were recorded with hybrid photo de-
tectors and Hoechst with a conventional multiplier tube. Images 
were analyzed offline using LAS X software (Leica) and ImageJ 
(National Institutes of Health).
To study MK and CD31 expression in murine cardiac sections, 
5-µm sections were deparaffinized, rehydrated, and incubated 
in antigen retrieval buffer (10 mM Tris-HCl, 2 mM EDTA, and 
10% glycerol, pH 9.0) at 110°C for 18 min. Thereafter, slides were 
allowed to cool at RT for 30 min, followed by a PBS rinse. Tissue 
sections were surrounded by a hydrophobic barrier using PAP 
pen and blocked for 10 min with 2.5% goat serum. Incubation 
with the primary Abs (rabbit anti-human MK Ab, clone EP1143Y 
[ab52637; Abcam]; rabbit anti-mouse CD31 Ab, clone D8V9E, 
[77699; Cell Signaling]) was performed on a shaker for 1 h at RT. 
Slides were washed in PBSt (0.05% Tween + 2 mM EDTA) be-
fore adding secondary Abs (ImmPRE SS HRP-conjugated goat 
anti-rabbit; MP-7401; Vector Laboratories). Sections were incu-
bated with secondary Abs for 30 min on a shaker followed by one 
PBSt (0.2% Tween + 2 mM EDTA) and two PBSt (0.05% Tween 
+ 2 mM EDTA) washes. Sections were subsequently incubated 
with tyramide signal amplification substrates. For multiplex 
staining, Ab stripping was performed in 10 mM citrate buffer 
(pH 6.2, 10% glycerol) in a pressure cooker at 110°C for 2 min be-
fore probing with the next primary Ab. To reduce red blood cell 
autofluorescence, slides were incubated at the end in TrueBlack 
Lipofuscin Autofluorescence Quencher (23007; Biotium; diluted 
500-fold in 70% ethanol) for 30 s. Following a DAPI counterstain, 
slides were coverslipped using Prolong Gold Antifade Mountant 
(P36930; Thermo Fisher). Slides were scanned with a 40×/NA 
0.95 objective (Zeiss) using the Zeiss Axioscan.Z1 (Whole Brain 
Microscopy Facility, University of Texas Southwestern Medical 
Center). DAPI, Alexa Fluor 488 (for OPAL520), Alexa Fluor 555 
(for OPAL570), and Alexa Fluor 660 (for OPAL 690) channels 
were used to acquire images. The exposure time for image ac-
quisition was between 5 and 100 ms. Images were prepared using 
Zen Lite (Zeiss).
To study NETosis in human cardiac biopsies, sections were 
incubated in HIER buffer (retriever-universal buffer, pH 7, 10 
× [Aptum APO 0530500]) at 45°C for 90 min. After antigen re-
trieval, sections were left in the HIER buffer at RT to cool below 
30°C, rinsed with deionized water three times and once with 
Tris-buffered saline (TBS), pH 7.4, and permeabilized for 5 min 
with 0.5% Triton X-100 in TBS, followed by three rinsing steps 
with TBS. Sections were surrounded with PAP pen and treated 
with blocking buffer for 30 min to prevent nonspecific binding. 
Primary Abs (rabbit anti-human H3Cit [ab5103; Abcam]; goat 
anti-human MPO [AF3667; R&D Systems]; and F(ab) Alexa Fluor 
633–conjugated mouse anti-H2A–H2B–DNA complex, provided 
by Prof. Marc Monestier, Temple University School of Medicine, 
Philadelphia, PA) were diluted in blocking buffer and incubated 
over night at 37°C. As secondary Abs, the Cy3-conjugated donkey 
anti-rabbit Ab (711–165-152; Dianova) and the Alexa Fluor 488–
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conjugated donkey anti-goat Ab (705–546-147; Dianova) were 
used. TBS supplemented with 1% BSA/2% donkey serum/5% 
cold water fish gelatin/0.05% Tween/0.05% Triton X-100 served 
as dilution and blocking buffer. Sections were mounted using 
Mowiol mounting medium (81381; Sigma-Aldrich) and screened 
for the presence of PMN using an Axioscan.Z1 slide scanner 
(Zeiss). Images of PMN-rich tissue areas were taken with a Leica 
TCS-SP8 confocal microscope equipped with a 63×/1.3 NA glyc-
erol immersion objective. Recording was conducted using hybrid 
photo detectors and conventional multiplier tubes. Images were 
analyzed offline using LAS AF software (Leica) and ImageJ (Na-
tional Institutes of Health).
STED nanoscopy
Microscopic inspection of the colocalization of LRP1 and CD11a 
in vitro was performed using STED nanoscopy. Isolated mu-
rine dHoxB8-LRP1ctrl cells were stained with a rabbit anti-LRP1 
Ab (clone EPR3724; ab195567; Abcam) and an Abberior STAR 
635-conjugated goat anti-rabbit Ab (2–0012-002-7; Abberior) 
as well as a rat anti-mouse CD11a Ab (clone 2D7; 553118; BD) and 
an Alexa Fluor 594–conjugated donkey anti-rat Ab (A-21209, 
RRID: AB_2535795; Thermo Fisher). Stained cells were perfused 
through microflow chambers (µ-slides IV 0.1; IBI DI) coated 
with ICAM-1 (02203; Stemcell), P-selectin (737-PS; R&D Sys-
tems), and MK (315–25; Peprotech) with a shear rate of 1 dyne/
cm2 at 37°C and subsequently fixated with PFA. STED nanos-
copy was conducted using a Leica TCS SP8 X White Light Laser 
STED microscope equipped with a 100×/1.4 NA oil immersion 
objective (Leica), depletion in the xy direction at 775 nm, and 
sequential recording. Alexa Fluor 594 and Abberior STAR 635 
were recorded with hybrid photo detectors. Images were ana-
lyzed offline using LAS X software (Leica) and ImageJ (National 
Institutes of Health).
Intravital microscopy
Intravital microscopy was performed using LRP1ctrl and LRP1cKO 
mice as well as C57Bl/6 mice 2 h after intrascrotal injection of 
TNFα (500 ng per mouse) as previously described (Weckbach 
et al., 2014). For experiments with C57Bl/6 mice, anti-N-MK 
Ab (Cellmid) or the matching isotype control Ab (clone MOPC-
21; 400101; BioLegend) were applied i.p. 12  h before the ex-
periment. Briefly, after cannulation of the carotid artery, the 
cremaster muscle was surgically prepared as reported previ-
ously (Weckbach et al., 2014). Intravital microscopy was con-
ducted using an upright microscope (Axiotech Vario, Zeiss; 
and DM6 FS, Leica) at 37°C and recorded using a digital camera 
(AxioCam HSm, Zeiss; and Zyla sCMOS, Andor Technology). 
Leukocyte counts were obtained from whole blood (ProCyte 
Dx; IDE XX Laboratories). Cells attached >30 s were defined as 
adherent. Diameter of postcapillary venules ranged from 20 to 
40 µm. Centerline red blood cell velocities in microvessels were 
analyzed using fluorescent microspheres (0.5 µm diameter; 
Polysciences). Blood flow was calculated from the length of at 
least three microspheres measured in a snapshot image with 
a defined exposure time and converted offline to mean blood 
flow velocities. Wall shear rates were calculated as previously 
described (Weckbach et al., 2014).
Cremaster muscle whole mounts
To assess the number of extravasated leukocytes, cremaster 
muscles were exteriorized and surgically prepared 2  h after 
intrascrotal application of TNFα (500 ng; 315-01A; Peprotech) 
as previously reported (Weckbach et al., 2014). Tissues were 
fixed, stained with Giemsa, and mounted (AGAR Scientific). The 
number of perivascular leukocytes was analyzed using a Leica 
DM2500 microscope with a 100×/1.4 NA oil-immersion objective 
(HCX PL APO). Images were obtained using a CMOS color camera 
(DMC2900 CMOS Sensor camera; Leica). Leukocyte subpopula-
tions were differentiated morphologically.
Spinning disk confocal microscopy
To study cell surface expression of LRP1 and CD11a of rolling and 
adherent cells under flow conditions, spinning-disk confocal 
microscopy was conducted. Isolated mPMNs or dHoxb8-LRP1ctrl 
cells were perfused through microflow chambers (µ-slides IV 
0.1; IBI DI) coated with ICAM-1 (02203; Stemcell), P-selectin (737-
PS; R&D Systems), and CXCL1 (250–11; Peprotech) as described 
below in detail. Imaging was conducted using an upright confocal 
microscope (Examiner, Zeiss) equipped with the confocal unit 
scanner CSU-X1 (Yokogawa Electric Corporation), a CCD cam-
era (Evolve; Photometrics), and a 20×/1.0 NA water-immersion 
objective (Plan Apochromat; Zeiss). 20 min before the experi-
ment, cells were stained with a FITC-labeled mouse anti-human 
LRP1 Ab (BioMac) as well as an allophycocyanin (APC)-labeled 
rat anti-mouse CD11a Ab (clone 2D7; 562810; BD) or an APC-la-
beled rat anti-mouse Gr-1 Ab (clone RB6-8C5; 108411, RRID: 
 AB _313376; BioLegend). Images were obtained using two lasers 
with an excitation wavelength of 488 nm and 640 nm. 6.0.8 
Software (3i) and Fiji/ImageJs plugin coloc2 (Daniel J. White, GE 
Healthcare, Aurora, OH) were used to analyze fluorescence in-
tensities (I) and colocalization parameters (Pearson’s correlation 
coefficient). Normalization of intensity values was calculated 
with following equation: [I(t) − I(min)]/[I(max) − I(min)], where 
t = time point, min = minimal fluorescence intensity, and max = 
maximum fluorescence intensity. All analyses were performed 
in a blinded manner.
Functional analysis of dHoxb8 cells under flow 
conditions in vitro
dHoxb8-LRP1cKO and dHoxb8-LRP1ctrl cells were analyzed in vitro 
using microflow chambers (µ-slides IV 0.1; IBI DI). Coating with 
P-selectin, ICAM-1, and murine MK or CXCL1 was performed 
for 12 h at 4°C before the experiment. After blocking the flow 
chambers for 2  h at RT, dHoxb8-LRP1cKO and dHoxb8-LRP1ctrl 
cells were suspended in adhesion medium (HBSS supplemented 
with 20 mM Hepes, 0.25% BSA, 0.1% glucose, 1.2 mM Ca2+, and 
1.0 mM Mg2+). Subsequently, dHoxb8 cells (7.5 × 105 cells/ml) 
were directly perfused through the flow chamber at constant 
shear stress (1 dyne/cm2) using a high-precision syringe pump 
(model KDS-232; KD Scientific). To study induction of adhesion, 
time-lapse videos were recorded from 18 different fields of view 
within the flow chamber at five different time points. Time-
lapse video microscopy was performed using the Zeiss Axiovert 
200M microscope equipped with a Plan-Apochromat 20×/0.75 
NA objective, AxioCam HR digital camera, and temperature-con-
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trolled environmental chamber at 37°C. The number of adherent 
dHoxb8 cells was determined for analysis of cell adhesion. For 
measurement of detachment under flow conditions, dHoxb8 
cells were seeded into flow chambers. After 10 min of incubation 
at 37°C, shear stress was applied and gradually increased from 
0.2 to 8.0 dyne/cm2 every 90 s. Time-lapse videos were recorded 
for 9 min, and relative adhesion was calculated for seven time 
points as the percentage of adherent cells relative to initially 
adherent cells at 0.2 dyne/cm2 (100%). The number of adher-
ent cells was analyzed offline using ImageJ (National Institutes 
of Health). To analyze mechanotactic crawling of dHoxb8 cells, 
shear stress (1 dyne/cm2) was applied for 10 min. The cell velocity 
and the Euclidian distance traveled by migration were measured 
using ImageJ with the manual tracking plugin (Fabrice Corde-
lies, Institute Curie, Paris, France). Migration analysis software 
provided by IBI DI was used for single-cell migration tracks. Cell 
spreading was analyzed by measuring the cell area after 10 min 
of flow (1 dyne/cm2) using ImageJ.
Flow cytometry
Surface expression of CD11a, CD11b, and CD18 was measured on 
isolated mPMNs (2.5 × 105/sample) from LRP1cKO and LRP1ctrl 
mice. PMNs were stimulated with recombinant murine TNFα for 
20 min at 37°C or left unstimulated as a control. Cell staining was 
performed with the APC-conjugated rat anti-mouse CD11a Ab 
(clone 2D7 [BD]; isotype: rat IgG2a [400544, RRID: AB _11147167; 
BioLegend]), PE-conjugated rat anti-mouse CD11b Ab (clone 
M1/70 [RM2804; Thermo Fisher]; isotype: rat IgG2b [21275534; 
ImmunoTools]), and the FITC-conjugated rat anti-mouse CD18 
Ab (clone C71/16 [553292; BD]; isotype: rat IgG2a [554688; BD]).
For analysis of myocardial leukocyte infiltration, flow cytom-
etry was performed from hearts of EAM mice treated with either 
the mouse anti-human N-MK Ab (clone IP10 [Cellmid]; isotype: 
mouse IgG1 [92196; BioLegend]) or the mouse anti-human C-MK 
Ab (clone IP14 [Cellmid]; isotype: mouse IgG2a [92394; BioLeg-
end]). To obtain single-cell suspensions, hearts were extracted 
and perfused with PBS. Next, hearts were cut in small pieces 
and incubated with Liberase (5401119001; Roche) for 45 min at 
37°C. After incubation, the suspension was mixed gently, filtered 
through a 40-µm cell strainer, washed, and suspended in PBS. 
Cells were labeled with a FITC-conjugated rat anti-mouse CD11b 
Ab (clone M1-70; 553310; BD), PE-conjugated rat anti-mouse 
Gr-1 Ab (clone RB6-8C5, 108407, RRID: AB _313372; BioLegend), 
PE-conjugated rat anti-mouse Ly6G Ab (clone 1A8, 127607; Bio-
Legend), peridinin-chlorophyll protein (PerCP)–conjugated rat 
anti-mouse CD45 Ab (clone 30F-11, 561047; BD), and pacific blue–
conjugated rat anti-mouse CD4 Ab (clone RM4-5, 558107; BD) and 
incubated for 30 min at RT. Matching isotype Abs served as con-
trols. Subsequently, cells were washed and resuspended in PBS 
supplemented with 1% BSA and immediately subjected to flow 
cytometry. All experiments were conducted using a Gallios flow 
cytometer (Beckman Coulter). Data were analyzed using FlowJo 
software (TreeStar).
RNA isolation and real-time PCR
Hearts of EAM or sham-treated control mice were removed, 
rinsed with PBS, and homogenized mechanically using an Ul-
tra-Turrax T8 homogenizer (IKA Labortechnik). RNA was iso-
lated using TRIzol (15596026; Thermo Fisher) according to the 
manufacturer’s protocol, and genomic DNA was digested using 
the DNase I Amplification Grade kit (18068015; Thermo Fisher). 
1 µg total RNA was transcribed into cDNA using the Omniscript 
RT kit (205111; Qiagen). Quantitative PCR was conducted using 
SsoAdvanced Universal SYBR Green Supermix (1725271; Bio-
Rad). Hypoxanthine-guanine phosphoribosyltransferase (HPRT) 
was used as reference gene. The following primers were used: 
MK (forward, 5′-GTC AAT CAC GCC TGT CCT CT-3′; reverse, 5′-CAA 
GTA TCA GGG TGG GGA GA-3′), HPRT (forward, 5′-ACA GGC CAG 
ACT TTG TTG GAT-3′; reverse, 5′-ACT TGC GCT CAT CTT AGG CT-3′). 
Data are presented as relative expression of MK normalized to 
HPRT. Mean expression level of sham samples was defined as 1.
CD4+ T cell proliferation
CD4+ T cells were MACS-sorted from erythrocyte-lysed mouse 
splenocytes in accordance to the manufacturer’s protocol 
(Miltenyi Biotec). Cells were labeled with 2.5 µM CFSE (C34554; 
Thermo Fisher) and activated with anti-CD3/CD28 beads (ratio 
2:1; Miltenyi Biotec) in 96-well round-bottom plates at 20,000 
cells per well. Cells were cultured for 3 d in RPMI 1640 medium 
supplemented with 10% FCS, penicillin/streptomycin, β-mer-
captoethanol, and sodium pyruvate (8793; Roth), 20 ng/ml IL-2 
(212–12; Peprotech), and nonessential amino acids (M7145; Sig-
ma-Aldrich) at 37°C and 5% CO2. Cell proliferation of the CD4+ 
cell population (APC-conjugated rat anti-mouse CD4 Ab, clone 
RM4-5 [553051; BD]) was analyzed with the LSR II Fortessa ana-
lyzer (BD) and FlowJo software (TreeStar).
ELI SA
Mouse hearts of EAM mice treated with anti-N-MK or an iso-
type Ab for control were thoroughly rinsed with ice-cold PBS and 
weighed. The cardiac tissue was cut into small pieces and homog-
enized in lysis buffer (100 mM Tris, pH 7.4, 150 mM NaCl, 1 mM 
EGTA, 1 mM EDTA, 1% Triton X-100, 0.5% sodium deoxycholate, 
phosphatase, and protease inhibitor cocktail) mechanically using 
an Ultra-Turrax T8 homogenizer (IKA Labortechnik). Samples 
were subsequently centrifuged for 20 min at 5,000 g at 4°C, and 
the supernatant was used for ELI SA. MIP2-α was quantified ac-
cording to the manufacturer’s protocol (USB-026622; US Biologi-
cal). The absorbance was measured with a microtiter plate reader 
at 450 nm. For each sample, duplicates were analyzed. The in-
tra-assay variation among the duplicates was <10%. The cytokine 
concentrations were calculated from the standard curves using 
linear regression analysis.
PCR
Genotyping PCR was performed with the thermocycler UNO II 
(Biometra), a Taq DNA polymerase (9PIM166; Promega), and 
specific primer sets (Metabion) according to standard proce-
dures. The following primers were used: LRP1 (forward, 5′-CAT 
ACC CTC TTC AAA CCC CTT CCTG-3′; reverse, 5′-GCA AGC TCT CCT 
GCT CAG ACC TGG-3′). Vav1-cre (forward, 5′-GCC TGC CCT CCC 
TGT GGA TGC CAC CT-3′; reverse, 5′-GTG GGC AGA AGG GGC AGC 
CAC ACC ATT-3′). After amplification, electrophoretic separation 
was performed with a gel containing 1.5% agarose (3810; Roth) 
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and 0.002% ethidium bromide (HP46; Roth). Detection was per-
formed with 366 nm UV light (Biometra).
SDS-PAGE and immunoblotting
Samples were incubated in lysis buffer containing 25 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 1% Triton X-100, and 
1% Na-deoxycholate ( D6750; Roth), 1  mM diisopropylfluoro-
phosphate (D0879; Sigma-Aldrich), 100 µM NaF (4503; Roth), 
and 200 µM Na-orthovanadate (0735; Roth) supplemented with 
protease inhibitors (Sigma-Aldrich) for 30 min at 4°C and subse-
quently centrifuged at 13,000 g for 1 min. The supernatant was 
boiled for 5 min at 95°C with 2× Laemmli buffer. Proteins were 
separated using a 10% acrylamide SDS-PAGE gel and electropho-
retically transferred to polyvinylidene difluoride membranes. 
After incubation with 5% milk in TBS with Tween 20 for 1 h, the 
following Abs were used: rabbit anti-LRP1 Ab (clone EPR3724; 
ab92544, RRID: AB _2234877; Abcam), goat anti-actin Ab (poly-
clonal; sc1616, RRID: AB _630836; Santa Cruz), peroxidase-con-
jugated goat anti-rabbit IgG Ab (A0554; Sigma-Aldrich), and 
peroxidase-conjugated rabbit anti-goat IgG Ab (401515; Calbio-
chem). For detection, a chemiluminescence kit (32106; Pierce) 
was used. Analysis was performed with a Hamamatsu 1394 OR-
CA-ERA camera, the Aequoria MDS Macroscopic Imaging Sys-
tem, and Wasabi software (Hamamatsu Photonics).
Statistical analysis
Data represent mean ± SEM. Statistical significance (P < 0.05) 
was determined with Sigma Plot v10.0 (Systat Software) using a 
Student’s t test, Mann-Whitney rank-sum test, or Kruskal-Wallis 
ANO VA or one-way ANO VA test.
Online supplemental material
Fig. S1 shows staining of DNA, NE, and H3cit in cardiac sections 
of EAM mice after targeting NETs with DNase. Fig. S2 demon-
strates MK expression and function during EAM. Fig. S3 illus-
trates that IgG1 control Abs do not affect EAM. Fig. S4 exhibits 
that LRP1 is involved in leukocyte infiltration in vivo. Fig. S5 
shows an important contribution of the MK–LRP1 axis for dif-
ferent PMN recruitment steps. Video 1 displays the systolic func-
tion after blocking MK in EAM mice using mouse echo. Video 2 
demonstrates the impact of LRP1 on leukocyte rolling and adhe-
sion in the inflamed mouse cremaster muscle in vivo. Video 3 
illustrates the expression of LRP1 and CD11a. Video 4 shows the 
expression of LRP1 and Gr-1 in murine PMNs during rolling and 
adhesion in vitro. Video 5 shows the colocalization of LRP1 and 
CD11a in adherent dHoxb8 cells. Video 6 displays the role of LRP1 
for MK-mediated crawling under flow conditions.
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